A phase II clinical trial of toripalimab in advanced solid tumors with polymerase epsilon/polymerase delta (POLE/POLD1) mutation
Article in Signal Transduction and Targeted Therapy (September 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Signal Transduction and Targeted Therapy (September 2024)
Article in Advances in Biological Regulation (August 2024)
Article in Sağlık Bilimleri Dergisi (July 2024)